MFEC:PA:PA-Lyxor Core MSCI EMU (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 13.976

Change

-0.06 (-0.41)%

Market Cap

USD 0.48B

Volume

28.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.03 (+0.06%)

USD 66.12B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.00 (+0.60%)

USD 10.74B
WRD:PA HSBC ETFs Public Limited Compa..

+0.09 (+0.28%)

USD 9.02B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.45 (-1.02%)

USD 7.57B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.50 (+0.79%)

USD 6.92B
HHH:PA HSBC ETFs Public Limited Compa..

+0.30 (+0.59%)

USD 6.65B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.93 (+0.29%)

USD 6.26B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.30%)

USD 5.24B
500U:PA Amundi Index Solutions - Amund..

+0.02 (+0.02%)

USD 4.58B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.07 (+0.74%)

USD 3.86B

ETFs Containing MFEC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.58% 74% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.58% 75% C 75% C
Trailing 12 Months  
Capital Gain 16.74% 63% D 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.74% 80% B- 83% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.14% 62% D 62% D
Dividend Return 8.14% 61% D- 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.20% 70% C- 86% B+
Risk Adjusted Return 99.34% 98% N/A 97% N/A
Market Capitalization 0.48B 69% C- 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike